Home
About
Overview
Sharing Data
ORCID
Help
History (4)
[Why not let patients die in peace?].
Editorial Commentary.
Editorial Commentary.
PF-06952229, a selective TGF-?-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Editorial Commentary.
Editorial Commentary. Urol Pract. 2016 May; 3(3):241.
View in:
PubMed
authors with profiles
Kelly L Stratton